Recent Finacing
Recent Raise
GO Therapeutics applies glycobiology and glycoproteomics to generate cancer-specific antibodies exposing tumor-specific antigens, supporting ADCs, bispecific T‑cell engagers and cell therapies, and advancing preclinical programs from Cambridge, MA.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor